SAREPTA THERAPEUTICS INC revenue breakdown overview

SAREPTA THERAPEUTICS INC revenue for the last year amounted to 21.12 B MXN, the most of which — 21.12 B MXN — came from its highest performing source at the moment, RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities, the year earlier bringing 18.20 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought SAREPTA THERAPEUTICS INC 21.12 B MXN, and the year before that — 18.20 B MXN.